Skip to main content
. 2019 May 15;26(1):542–550. doi: 10.1080/10717544.2019.1616237

Figure 6.

Figure 6.

In vivo antitumor efficacy against 4T1 xenograft tumors after the intravenous and oral administration of DTX solution, DTX SNEDDS and Co-loaded SNEDDS. (A) Tumor volume (n = 5). (B) Images of tumors. (C) Tumor burden (n = 5). (D) Body weight changes (n = 5). (E) H&E staining of the major organs and tumor acquired from mice bearing 4T1 tumors at the tenth day after various treatments. Scale bars represent 100 μm. (* p< .05, **p < .01).